Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc.

No trades
See on Supercharts

Price target

2.480.000.00%
The 2 analysts offering 1 year price forecasts for CYTH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to CYTH in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CYTH EPS for the last quarter is −0.21 USD despite the estimation of −0.16 USD. In the next quarter EPS is expected to reach −0.16 USD. Track more of Cyclo Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cyclo Therapeutics, Inc. revenue is expected to reach ‪294.00 K‬ USD. Check out Cyclo Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CYTH price target is 2.48 USD with a max estimate of 4.00 USD and a min estimate of 0.95 USD. Check if this forecast comes true in a year, meanwhile watch Cyclo Therapeutics, Inc. stock price chart and keep track of the current situation with CYTH news and stock market news.